Cargando…

Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins

Chronic kidney disease (CKD) is a highly prevalent condition and is associated with a high comorbidity burden, polymedication, and a high mortality rate. A number of conventional and nonconventional risk factors for comorbidities and mortality in CKD have been identified. Among the nonconventional r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laville, Solène M., Massy, Ziad A., Kamel, Said, Chillon, Jean Marc, Choukroun, Gabriel, Liabeuf, Sophie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911578/ https://www.ncbi.nlm.nih.gov/pubmed/33530404 http://dx.doi.org/10.3390/toxins13020091

Ejemplares similares

Uremic Toxins and Vascular Dysfunction
por: Six, Isabelle, et al.
Publicado: (2020)

The Impact of Uremic Toxins on Vascular Smooth Muscle Cell Function
por: Hénaut, Lucie, et al.
Publicado: (2018)

Association between Uremic Toxin Concentrations and Bone Mineral Density after Kidney Transplantation
por: Batteux, Benjamin, et al.
Publicado: (2020)

The Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders
por: Assem, Maryam, et al.
Publicado: (2018)

Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation
por: Liabeuf, Sophie, et al.
Publicado: (2018)

Does P-Cresylglucuronide Have the Same Impact on Mortality as Other Protein-Bound Uremic Toxins?
por: Liabeuf, Sophie, et al.
Publicado: (2013)

Serum Calcification Propensity Represents a Good Biomarker of Vascular Calcification: A Systematic Review
por: Pluquet, Maxime, et al.
Publicado: (2022)

Protein-Bound Uremic Toxins: New Insight from Clinical Studies
por: Liabeuf, Sophie, et al.
Publicado: (2011)

Difference in Profiles of the Gut-Derived Tryptophan Metabolite Indole Acetic Acid between Transplanted and Non-Transplanted Patients with Chronic Kidney Disease
por: Liabeuf, Sophie, et al.
Publicado: (2020)

The Prescription of Drugs That Inhibit Organic Anion Transporters 1 or 3 Is Associated with the Plasma Accumulation of Uremic Toxins in Kidney Transplant Recipients
por: André, Camille, et al.
Publicado: (2021)

Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?
por: El Chamieh, Carolla, et al.
Publicado: (2022)

Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease
por: El Chamieh, Carolla, et al.
Publicado: (2023)

The Role of Gut-Derived, Protein-Bound Uremic Toxins in the Cardiovascular Complications of Acute Kidney Injury
por: Caillard, Pauline, et al.
Publicado: (2022)

N-methyl-2-pyridone-5-carboxamide (2PY)—Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin
por: Lenglet, Aurélie, et al.
Publicado: (2016)

From old uraemic toxins to new uraemic toxins: place of ‘omics’
por: Massy, Ziad A, et al.
Publicado: (2018)

The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial
por: Bennis, Youssef, et al.
Publicado: (2019)

Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation
por: Marienne, Justine, et al.
Publicado: (2020)

Potential interactions between uraemic toxins and drugs: an application in kidney transplant recipients treated with calcineurin inhibitors
por: André, Camille, et al.
Publicado: (2021)

The Addition of Vascular Calcification Scores to Traditional Risk Factors Improves Cardiovascular Risk Assessment in Patients with Chronic Kidney Disease
por: Liabeuf, Sophie, et al.
Publicado: (2015)

Association between Free Light Chain Levels, and Disease Progression and Mortality in Chronic Kidney Disease
por: Desjardins, Lucie, et al.
Publicado: (2013)

Drugs associated with incident fragility fractures in kidney transplant recipients
por: Batteux, Benjamin, et al.
Publicado: (2022)

Association between Dental Scores and Saliva Uremic Toxins
por: Rigothier, Claire, et al.
Publicado: (2023)

Gut-Derived Protein-Bound Uremic Toxins
por: Graboski, Amanda L., et al.
Publicado: (2020)

The AKI-to-CKD Transition: The Role of Uremic Toxins
por: André, Camille, et al.
Publicado: (2023)

Gut Microbiota Dynamics and Uremic Toxins
por: Mishima, Eikan, et al.
Publicado: (2022)

Effect of Sevelamer and Nicotinamide on Albumin Carbamylation in Patients with End-Stage Kidney Disease
por: Lenglet, Aurelie, et al.
Publicado: (2021)

Correlation between Saliva Levels and Serum Levels of Free Uremic Toxins in Healthy Volunteers
por: Fabresse, Nicolas, et al.
Publicado: (2023)

Cellular and molecular mechanisms associated with ischemic stroke severity in female mice with chronic kidney disease
por: Hénaut, Lucie, et al.
Publicado: (2019)

The Impact of CKD on Uremic Toxins and Gut Microbiota
por: Rysz, Jacek, et al.
Publicado: (2021)

Gut Microbiota as a Source of Uremic Toxins
por: Popkov, Vasily A., et al.
Publicado: (2022)

Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis
por: Deltombe, Olivier, et al.
Publicado: (2015)

Derivation and elimination of uremic toxins from kidney-gut axis
por: Xu, Ying, et al.
Publicado: (2023)

Effects of Chronic Kidney Disease and Uremic Toxins on Extracellular Vesicle Biology
por: Yaker, Linda, et al.
Publicado: (2020)

The Interplay between Uremic Toxins and Albumin, Membrane Transporters and Drug Interaction
por: da Cunha, Regiane Stafim, et al.
Publicado: (2022)

Risk factors for and characteristics of community‐ and hospital‐acquired drug‐induced acute kidney injuries
por: Rey, Amayelle, et al.
Publicado: (2022)

Does kidney transplantation influence a form of discrimination for antihypertensive drugs prescriptions?
por: Cheddani, Lynda, et al.
Publicado: (2021)

The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients
por: de Oliveira, Rodrigo Bueno, et al.
Publicado: (2013)

Use of the Capture-Recapture Method to Estimate the Frequency of Community- and Hospital-Acquired Drug-Induced Acute Kidney Injuries in French Databases
por: Rey, Amayelle, et al.
Publicado: (2022)

Consequences of oral antithrombotic use in patients with chronic kidney disease
por: Laville, Solène M., et al.
Publicado: (2021)

Urea levels and cardiovascular disease in patients with chronic kidney disease
por: Laville, Solène M, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_leh6av9te4c0f4m3se09dsdli2